<DOC>
	<DOCNO>NCT02474849</DOCNO>
	<brief_summary>This study compare nicotine delivery , heart rate , puff parameter product satisfaction healthy subject either use several different type electronic cigarette smoke conventional cigarette .</brief_summary>
	<brief_title>Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes Conventional Cigarette Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>1 . Prior study start , subject must daily user new generation ecigarette device use regularly minimum three month . The solution use ecigarettes must contain nicotine . Subjects must also occasional smoker combustible cigarette ( low limit 1 cigarette per month ; upper limit 5 cigarette per week ) . Product use status confirm urinary cotinine level â‰¥200ng/ml ( determine use NicAlert cotinine test kit ) screening . 2 . Subjects males nonpregnant , nonlactating female , 21 55 year age inclusive . Age verification perform check Federal stateissued ID ( e.g . passport drive licence ) screening . 3 . Women childbearing potential use one follow acceptable method contraception : combine ( oestrogen progestogen contain ) oral , intravaginal transdermal hormonal contraception associate inhibition ovulation ; progestogenonly hormonal contraception , either oral , injected implant , associate inhibition ovulation ; progestogenonly oral hormonal contraception inhibition ovulation primary mode action ; intrauterine device ( IUD ) ; intrauterine hormonereleasing system ( IUS ) ; bilateral tubal occlusion ; male female condom without spermicide ; cap , diaphragm sponge spermicide . 4 . Women nonchildbearing potential may include either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal 1 year must negative urine pregnancy test result screen . Women surgically sterile must provide documentation procedure operative report . 5 . Male subject must use approved method birth control entire study . These subject must donate sperm time . 6 . Subjects must good health determine medical history , vital sign , blood biochemistry , haematology , urinalysis physical examination . 7 . Subjects must body mass index ( BMI ) 18 30 kg/m2 inclusive . Male subject must weight 60 120kg female subject 50 100kg . 8 . No clinically significant abnormality blood pressure value . 9 . Subjects negative result urinary drug abuse screen ethanol test . 10 . Subjects give write informed consent participate study abide study restriction . To confirm clinic visit : 1 . Abstinence tobacco nicotine product confirm exhaled breath CO reading &lt; 10ppm . 1 . Subjects history , clinically active significant , neurological , gastrointestinal , renal , hepatic , cardiovascular , psychiatric , respiratory , metabolic , endocrine , haematological disease major disorder . 2 . Subjects significant allergy opinion Principal Investigator include . 3 . Subjects diagnose urticaria ( hive ) asthma . 4 . Persons history urticaria ( hive ) response product . 5 . Subjects recent history current drug alcohol abuse opinion Investigator include . Excessive intake alcohol within last 6 month , define regular maximum weekly intake great 7 drink woman 14 drink men . One drink define one pint regular beer ( 5 % alcohol ) , 200 ml wine ( 12 % alcohol ) , 25 ml distil spirit ( 40 % alcohol ) . 6 . Subjects inability communicate well Investigator/study staff ( i.e. , language problem , poor mental development impair cerebral function ) . 7 . Subjects participate another clinical research study participate clinical research study last 3 month . 8 . Subjects treatment prescription medication within 21 day overthecounter medication within 24 hour plan first product use occasion , except state Inclusion Criteria . For subject , prescribe use blood pressure ( beta blocker ) lipid lower ( statin ) medication permit . 9 . Subjects use drug substance ( except tobacco ) know strong inducer inhibitor CYP enzyme ( formerly know cytochrome P450 enzyme ) within 28 day period prior first product administration . For list drug substance , please refer http : //medicine.iupui.edu/clinpharm/ddis/maintable/ . 10 . Subjects treatment smoke cessation medication ( e.g . Bupropion , Chantix NRT ) within 30 day plan first product use occasion . 11 . Subjects clinically significant medical history , Investigator 's opinion , include condition might affect drug absorption , metabolism excretion . 12 . Female subject , pregnant become pregnant course study . 13 . Subjects lose donated 450ml blood within 3 month precede first product administration . 14 . Subjects currently try stop smoking stop use ecigarettes , consider stop next two month . 15 . Subjects unwilling unable comply study requirement . 16 . Subjects opinion Investigator participate study reason . To reconfirm clinic visit : 1 . Subject continue meet screen exclusion criterion . 2 . Receipt medication since screen visit may impact safety objective study ( Principal Investigator 's discretion ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>